| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
FibroBiologics, Inc.
13D
FBLG · 31573L204
|
7.5% |
9/17/2026
Event 9/15/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.